Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma

Chinese Journal of Contemporary Pediatrics

Volumn 11, Issue 11, 2009, Pages 885-887

  Feng, Chen ^a   Tang, Suo Qin ^a   Wang, Jian Wen ^a   Liu, Ying ^a   Yang, Guang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chemotherapy; Child; Neuroblastoma; Toxicity

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ABDOMEN; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIGESTIVE SYSTEM INJURY; DISEASE SEVERITY; DRUG MONITORING; HEART INJURY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INFECTION; KIDNEY INJURY; LIVER INJURY; MEDIASTINUM; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; NEUROTOXICITY; NEUTROPENIA; PELVIS; PREOPERATIVE CARE; PRESCHOOL CHILD; SCHOOL CHILD; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; ETOPOSIDE; FEMALE; HUMANS; INFANT; MALE; NEUROBLASTOMA; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 71049138131     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology[J]. Lancet Oncol, 2003, 4(8):472-480. (Pubitemid 37009955)
2. Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, et al. The role of surgery in stage IV neuroblastoma [J]. J Pediatr Surg, 2002, 37(11):1574-1578.
3. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma [J]. J Clin Oncol, 2004, 22(24):4888-4892. (Pubitemid 46638612)
4. McWilliams NB, Hayes FA, Green AA, Smith EI, Nitschke R, Altshuler GA, et al. Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study[J]. Med Pediatr Oncol, 1995, 24(3): 176-180.
5. Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, et al. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma[J]. Pediatr Blood Cancer, 2009, 53(1):17-22.